Part D Pricing and Subpoena Power: What the November Elections Could Mean for Wall Street

The pharmaceutical industry has a lot riding on the mid-term elections: the Democrats only need to take back one chamber of Congress to do damage on Wall Street.

By Kate Rawson

For Big Pharma, there may be nothing more dangerous than a House Democrat 12 years out of power and itching...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Agency Leadership

More from Pink Sheet